Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;41(1):40-59.
doi: 10.1016/j.biocel.2008.06.010. Epub 2008 Jul 9.

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Affiliations
Review

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Bharat B Aggarwal et al. Int J Biochem Cell Biol. 2009 Jan.

Abstract

Although safe in most cases, ancient treatments are ignored because neither their active component nor their molecular targets are well defined. This is not the case, however, with curcumin, a yellow-pigment substance and component of turmeric (Curcuma longa), which was identified more than a century ago. For centuries it has been known that turmeric exhibits anti-inflammatory activity, but extensive research performed within the past two decades has shown that this activity of turmeric is due to curcumin (diferuloylmethane). This agent has been shown to regulate numerous transcription factors, cytokines, protein kinases, adhesion molecules, redox status and enzymes that have been linked to inflammation. The process of inflammation has been shown to play a major role in most chronic illnesses, including neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. In the current review, we provide evidence for the potential role of curcumin in the prevention and treatment of various proinflammatory chronic diseases. These features, combined with the pharmacological safety and negligible cost, render curcumin an attractive agent to explore further.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Inhibition of inflammatory pathways by curcumin. BACE-1, beta-site APP-cleaving enzyme 1; CRP, C-reactive protein; CTGF, connective tissue growth factor; ELAM-1, endothelial leukocyte adhesion molecule-1; HAT, histone acetyl transferase; HIF, hypoxia inducible factor; ICAM-1, intracellular adhesion molecule-1; LPO, lipid peroxidation; MMP, matrix metalloprotease ; NF-κB, nuclear factor kappa B; ODC, ornithine decarboxylase; STAT, signal transducers and activator of transcription protein; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule-1; VEGF, vascular endothelial growth factor.
Fig. 2
Fig. 2
Effect of curcumin on various proinflammatory diseases.

References

    1. Abdou AG, Hanout HM. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. J Cutan Pathol. 2008;35:445–451. - PubMed
    1. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999;39:41–47. - PubMed
    1. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745–756. - PubMed
    1. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004;6:203–208. - PubMed
    1. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature. 1985a;318:665–667. - PubMed

Publication types

MeSH terms